Related Experiment Videos
Dialysis modality and dosing strategy in acute renal failure
1Renal Section, VA Pittsburgh Healthcare System, and University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15240, USA. palevsky@pitt.edu
Seminars in Dialysis
|March 23, 2006
Summary
Management of renal replacement therapy (RRT) for acute renal failure (ARF) needs clarification. Current evidence is conflicting on optimal RRT initiation timing and modality, highlighting the need for further research in critical care nephrology.
Area of Science:
- Nephrology
- Critical Care Medicine
- Renal Replacement Therapy
Background:
- Optimal management strategies for renal replacement therapy (RRT) in acute renal failure (ARF) remain incompletely defined.
- While initiation of RRT around BUN 90-100 mg/dl is supported, earlier intervention benefits are debated.
- Uncertainty exists regarding the comparative efficacy of different RRT modalities.
Purpose of the Study:
- To review unresolved issues in RRT for ARF.
- To examine the evidence for RRT initiation timing.
- To assess the relative effectiveness of various RRT modalities and optimal dosing strategies.
Main Methods:
- Review of existing literature and data from multiple studies on RRT in ARF.
- Comparison of continuous renal replacement therapy (CRRT) versus intermittent hemodialysis (IHD).
- Analysis of optimal dosing parameters, including Kt/Vurea for IHD and flow rates for CRRT.
Main Results:
- No demonstrated survival benefit or improved renal recovery for CRRT over IHD despite increased utilization.
- Optimal Kt/Vurea and treatment frequency for IHD are not established.
- While CVVH dosing at 35 ml/kg/hr (postdilution) is suggested, confirmation and validation for other CRRT modalities are needed.
Conclusions:
- Significant uncertainties persist regarding RRT management in ARF, including initiation timing, modality choice, and dosing.
- Further research is required to establish evidence-based guidelines for RRT in ARF.
- Optimizing RRT protocols is crucial for improving patient outcomes in acute kidney injury.
Related Concept Videos
01:20Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
01:27Dialysis
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
01:15Dialysis
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:30Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...